ESI Stock Analysis: Element Solutions | NYSE
Specialty Chemicals | NYSE, USA | Market Cap: 10.631m USD | 12M Return: 63% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 182M
EPS Trend: 97.7%
Qual. Beats: 2
Rev. Trend: 88.0%
Qual. Beats: 2
Warnings
No concerns identified
Tailwinds
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Element Solutions Inc (ESI) is a specialty chemicals technology company headquartered in Miami Beach, Florida, with operations in the United States, China, and other international markets. The company is organized into two reporting segments: MacDermid Alpha Electronics Solutions, which supplies assembly, circuitry, and semiconductor packaging materials to mobile communications, computing, automotive, and aerospace equipment manufacturers; and Element Specialties, which provides industrial finishing products (such as electroless nickel, plating, and pre-treatment solutions) and energy-sector fluids to aerospace, automotive, construction, consumer electronics, and oil and gas customers. The company was originally founded in 1785 and was formerly known as Platform Specialty Products Corporation before adopting its current name in January 2019.
As a participant in the specialty chemicals sub-industry, Element Solutions competes in a market where products are typically sold based on performance characteristics and technical specifications rather than chemical composition, and where formulations are often tailored to individual customer applications. The business model relies on deep technical integration with customers manufacturing processes, which tends to create high switching costs and long product qualification cycles, particularly in electronics assembly and semiconductor packaging applications.
- Semiconductor packaging demand surges on AI server buildout
- Energy solutions revenue tracks offshore oil and gas activity
- China tariff exposure pressures specialty chemicals pricing
| Net Income: 148.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA -3.55 > 1.0 |
| NWC/Revenue: 32.70% < 20% (prev 41.04%; Δ -8.34% < -1%) |
| CFO/TA 0.03 > 3% & CFO 197.2m > Net Income 148.7m |
| Net Debt (2.00b) to EBITDA (335.8m): 5.94 < 3 |
| Current Ratio: 2.68 > 1.5 & < 3 |
| Outstanding Shares: last quarter (243.7m) vs 12m ago 0.29% < -2% |
| Gross Margin: 40.85% > 18% (prev 42.06%; Δ -1.21% > 0.5%) |
| Asset Turnover: 53.12% > 50% (prev 51.63%; Δ 1.49% > 0%) |
| Interest Coverage Ratio: 2.96 > 6 (EBIT TTM 179.3m / Interest Expense TTM 60.6m) |
| A: 0.16 (Total Current Assets 1.46b - Total Current Liabilities 543.6m) / Total Assets 5.74b |
| B: -0.15 (Retained Earnings -868.5m / Total Assets 5.74b) |
| C: 0.03 (EBIT TTM 179.3m / Avg Total Assets 5.27b) |
| D: 0.92 (Book Value of Equity 2.73b / Total Liabilities 2.99b) |
| Altman-Z'' = 1.74 = BBB |
| DSRI: 1.32 (Receivables 676.9m/454.7m, Revenue 2.80b/2.48b) |
| GMI: 1.03 (GM 42.06% / 40.85%) |
| AQI: 1.03 (AQ_t 0.68 / AQ_t-1 0.66) |
| SGI: 1.13 (Revenue 2.80b / 2.48b) |
| TATA: -0.01 (NI 148.7m - CFO 197.2m) / TA 5.74b) |
| Beneish M = -2.63 (Cap -4..+1) = A |
As of July 09, 2026, the stock is trading at USD 39.34 with a total of 11,441,207 shares traded. Over the past week, the price has changed by -17.61%, over one month by -2.02%, over three months by +6.81% and over the past year by +62.98%.
Current recommended Stop Loss: 36.20 (which is 8% or 1.3 ATR below the current price).
Element Solutions has received a consensus analysts rating of 4.55. Therefore, it is recommended to buy ESI.
- StrongBuy: 7
- Buy: 3
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 48 | 22% |
P/E Trailing = 70.3871
P/E Forward = 26.1097
P/S = 3.8002
P/B = 4.0741
Revenue TTM = 2.80b USD
EBIT TTM = 179.3m USD
EBITDA TTM = 335.8m USD
Long Term Debt = 2.06b USD (from longTermDebt, last quarter)
Short Term Debt = 97.9m USD (from shortTermDebt, last quarter)
Debt = 2.17b USD (from shortLongTermDebtTotal, last quarter) + Leases 16.5m
Net Debt = 2.00b USD (calculated: Debt 2.17b - CCE 177.3m)
Enterprise Value = 12.6b USD (10.6b + Debt 2.17b - CCE 177.3m)
Interest Coverage Ratio = 2.96 (Ebit TTM 179.3m / Interest Expense TTM 60.6m)
EV/FCF = 104.4x (Enterprise Value 12.6b / FCF TTM 120.9m)
FCF Yield = 0.96% (FCF TTM 120.9m / Enterprise Value 12.6b)
FCF Margin = 4.32% (FCF TTM 120.9m / Revenue TTM 2.80b)
Net Margin = 5.32% (Net Income TTM 148.7m / Revenue TTM 2.80b)
Gross Margin = 40.85% ((Revenue TTM 2.80b - Cost of Revenue TTM 1.65b) / Revenue TTM)
Gross Margin QoQ = 38.42% (prev 40.91%)
Tobins Q-Ratio = 2.20 (Enterprise Value 12.6b / Total Assets 5.74b)
Interest Expense / Debt = 2.79% (Interest Expense 60.6m / Debt 2.17b)
Taxrate = 32.29% (26.7m / 82.7m)
NOPAT = 121.4m (EBIT 179.3m * (1 - 32.29%))
Current Ratio = 2.68 (Total Current Assets 1.46b / Total Current Liabilities 543.6m)
Debt / Equity = 0.79 (Debt 2.17b / totalStockholderEquity, last quarter 2.73b)
Debt / EBITDA = 5.94 (Net Debt 2.00b / EBITDA 335.8m)
Debt / FCF = 16.51 (Net Debt 2.00b / FCF TTM 120.9m)
Total Stockholder Equity = 2.67b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.82% (Net Income 148.7m / Total Assets 5.74b)
RoE = 5.56% (Net Income TTM 148.7m / Total Stockholder Equity 2.67b)
RoCE = 3.79% (EBIT 179.3m / Capital Employed (Equity 2.67b + L.T.Debt 2.06b))
RoIC = 2.36% (NOPAT 121.4m / Invested Capital 5.15b)
WACC = 9.91% (E(10.6b)/V(12.8b) * Re(11.55%) + D(2.17b)/V(12.8b) * Rd(2.79%) * (1-Tc(0.32)))
Discount Rate = 11.55% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 34.92 | Cagr: 0.33%
[DCF] Terminal Value 67.49% ; FCFF base≈180.9m ; Y1≈158.7m ; Y5≈128.2m
[DCF] Fair Price = N/A (negative equity: EV 1.64b - Net Debt 2.00b = -357.7m; debt exceeds intrinsic value)
EPS Correlation: 97.74 | EPS CAGR: 7.77% | SUE: 4.0 | # QB: 2
Revenue Correlation: 88.03 | Revenue CAGR: 5.27% | SUE: 4.0 | # QB: 2
EPS current Quarter (2026-06-30): EPS=0.43 | Chg30d=-1.97% | Revisions=-50% | Analysts=10
EPS next Quarter (2026-09-30): EPS=0.46 | Chg30d=-1.07% | Revisions=-36% | Analysts=10
EPS current Year (2026-12-31): EPS=1.77 | Chg30d=+1.26% | Revisions=+70% | GrowthEPS=+18.8% | GrowthRev=+35.7%
EPS next Year (2027-12-31): EPS=2.05 | Chg30d=+2.64% | Revisions=+58% | GrowthEPS=+16.0% | GrowthRev=+7.5%
[Analyst] Revisions Ratio: +15% (up=18, down=13)